Using advanced imaging technology to more precisely target radiation beams to treat soft tissue cancers (sarcomas) in the extremities significantly reduces long term side effects without effecting survival rates, according to research results published online in the Journal of Clinical Oncology.

Meridian Medical Systems announced it has received U.S. Food and Drug Administration (FDA) clearance to market its Meridian Monarch ultra high definition (UHD) Universal Digital Imager (UDI) with wireless detector and automatic exposure detection (AED). The approval process included the Monarch UDI 2 and the Monarch UDI 2 with wireless/AED. The digital system has been cleared to be used for both pediatric and adult radiographic imaging.

breast cancer, radiation therapy, chemotherapy, mastectomy

Breast cancer patients who undergo a mastectomy should receive subsequent radiation treatment if their cancer has spread to four or more nearby lymph nodes. However, according to a new study, only 65 percent of these women are getting the recommended postmastectomy radiation therapy (PMRT).
lung cancer, Lung-RADS, ACR, guidelines, study, CT, computed tomography

A set of guidelines developed to help standardized lung cancer screening would have generated considerably fewer false-positives than the National Lung Screening Trial produced, according to a new retrospective study.
Sanovas, lung cancer screening, peripheral tumors, PDT, Medicare

Sanovas Inc. announced that one of its clinical advisers is warning that the United States healthcare system faces a shortage of therapeutic resources as Medicare coverage of lung cancer screening for at-risk beneficiaries goes into effect. Lung cancer is the leading cause of cancer death and the second-leading cause of all deaths in the United States.
Oncology related products, focused ultrasound therapy, MRI systems

A pioneering clinical trial is testing whether focusing high-frequency sound waves onto the surface of bone where cancer has spread can burn away the source of pain.

In a surprising finding, a collaborative national clinical trials group (RTOG) including Dartmouth-Hitchcock's Alan Hartford, M.D., Ph.D., discovered that radiation therapy in addition to chemotherapy was even more effective at preventing recurrence of ductal carcinoma in situ (DCIS) than previously thought. 

Prostate cancer patients with detectable prostate specific antigen (PSA) following radical prostatectomy should receive earlier, more aggressive radiation therapy treatment, according to a study published in the February 1, 2015 issue of the International Journal of Radiation Oncology • Biology • Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO). 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now